ScoreWhy is Brawn Biotech Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
- Poor long term growth as Net Sales has grown by an annual rate of -14.63% and Operating profit at -8.25% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.25
2
Flat results in Sep 25
- CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 0.19 cr
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -5.84%, its profits have risen by 66.5%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Brawn Biotech for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Brawn Biotech
-5.84%
-0.10
59.07%
Sensex
4.74%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-14.63%
EBIT Growth (5y)
-8.25%
EBIT to Interest (avg)
-1.25
Debt to EBITDA (avg)
0.23
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
2.97
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.35%
ROCE (avg)
-26.36%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
27
Price to Book Value
1.62
EV to EBIT
-5.81
EV to EBITDA
-5.81
EV to Capital Employed
1.66
EV to Sales
0.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-25.36%
ROE (Latest)
-16.49%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET SALES(Latest six months)
At Rs 10.69 cr has Grown at 45.24%
PAT(Latest six months)
Higher at Rs 0.31 cr
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.19 cr
Loading Valuation Snapshot...
Here's what is working for Brawn Biotech
Net Sales - Latest six months
At Rs 10.69 cr has Grown at 45.24%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 0.31 cr
than preceding 12 month period ended Sep 2025 of Rs -1.79 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Brawn Biotech
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.19 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
